Tincu et al. evaluated albumin-based systems for glioblastoma treatment [11], Lamichhane and Lee examined “albumin nanoscience” in cancer-targeting [12], Hornok detailed serum AlNPs production and clinical uses [13], Hoogenboezem et al. classified albumin delivery methodologies [14], and Zha et al. investigated functionalized nanomaterials traversing the BBB [15], though albumin was not specifically highlighted. Here, ALB is linked to cancer.